Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.
Gao W, Zhang X, Yang W, Dou D, Zhang H, Tang Y, Zhong W, Meng J, Bai Y, Liu Y, Yang L, Chen S, Liu H, Yang C, Sun T.
Gao W, et al. Among authors: yang c, yang l, yang w.
J Immunother Cancer. 2019 Aug 28;7(1):231. doi: 10.1186/s40425-019-0676-z.
J Immunother Cancer. 2019.
PMID: 31462297
Free PMC article.